The ongoing dispute between aspiring health science has finally met its end as all the classified data relating to the lead product of the company known as ACP-01 has been returned to Hemostemix by the defendant.

https://hemostemix.com/intellectual-property-...completed/

https://www.otcmarkets.com/stock/HMTXF/news/H...?id=351995

https://www.newsfilecorp.com/redirect/7exnWhZAxj

https://www.newsfilecorp.com/release/120166

https://www.youtube.com/watch?v=s8UUx_mh_E8

https://hemostemix.com/ceo-updates/